Should you buy NXTC stock?

Last updated:

Based on market data through , StockInvest.us rates NextCure Inc. (NXTC) as a Strong Buy Candidate with a technical score of 5.90 on its -10 to +10 scale. This is an upgrade from Hold in the previous daily evaluation.

  • Buy signal since
  • Price since signal Up 18.34%
  • 3-month trend forecast Down 29.09%
  • Strong Buy Candidate 5.90
AI Analysis AI Analysis of NXTC AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add NXTC to Watchlist?
Some Reasons Why To Add NXTC:
  • Highly efficient cash conversion (100% FCF/OCF ratio)
  • +42.5% price growth over the last year
  • Established player in the Healthcare sector
PDF

Big movements in NextCure Inc. stock price on Monday moving 21.27% between high and low
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Aug 04, 2026 Gain 18.34%

The NextCure Inc. stock price gained 17.12% on the last trading day (Monday, 10th Aug 2026), rising from $5.84 to $6.84. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 21.27% from a day low at $5.91 to a day high of $7.17. The price has risen in 7 of the last 10 days and is up by 33.59% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 1 million more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $9.50 million.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $7.51 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -29.09% during the next 3 months and, with a 90% probability hold a price between $0.147 and $5.33 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

NXTC Signals & Forecast

The NextCure Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $5.41 and $3.85. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, June 30, 2026, and so far it has risen 327.50%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for NextCure Inc. stock

NextCure Inc. finds support from accumulated volume at $6.63 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $1.26 between high and low, or 21.27%. For the last week, the stock has had daily average volatility of 20.93%.

Our recommended stop-loss: $6.58 (-3.76%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from a pivot bottom found 28 days ago.)

Trading Expectations (NXTC) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect NextCure Inc. to open at $6.64, and during the day (based on 14 day Average True Range), to move between $6.37 and $7.31, which gives a possible trading interval of +/-$0.95 (+/-14.89%) up or down from last closing price. If NextCure Inc. takes out the full calculated possible swing range there will be an estimated 14.89% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $7.02 (2.63%) than the support at $6.63 (3.07%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is NextCure Inc. stock A Buy?

NextCure Inc. holds several positive signals and despite the stock being in a falling trend, we considered it to be a good choice at these current levels. We expect NextCure Inc. stock will perform very well in the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Strong Buy candidate.

Current score: 5.898 Strong Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $6.64 ( 2.94%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

NXTC Performance

Trading levels for NXTC

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 7.90 15.44%
R2 7.42 8.42%
R1 7.12 4.08%
Price 6.84
S1 6.16 -9.96%
S2 5.86 -14.30%
S3 5.38 -21.32%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 7.83 14.47%
R1 7.02 2.63%
Price 6.84
S1 6.63 -3.07%
S2 6.58 -3.80%
S3 6.17 -9.80%

FAQ

What is the symbol for NextCure Inc. Stock and on which exchange is it traded?
The symbol for NextCure Inc. is NXTC and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell NextCure Inc. Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates NextCure Inc. (NXTC) as a Strong Buy Candidate with a technical score of 5.90 on its -10 to +10 scale. This is an upgrade from Hold in the previous daily evaluation. Since the Buy signal began on Aug 04, 2026, the price has risen 18.34%. The current 3-month trend forecast projects a fall of 29.09%.

How to buy NextCure Inc. Stock?
NextCure Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy NextCure Inc. Stock.

What's the current price of NextCure Inc. Stock?
As of the end of day on the Aug 10, 2026, the price of an NextCure Inc. (NXTC) share was $6.84.

What is the 52-week high and low for NextCure Inc. Stock?
The 52-week high for NextCure Inc. Stock is $15.74 and the 52-week low is $1.55.

What is the market capitalization of NextCure Inc. Stock?
As of the Aug 10, 2026, the market capitalization of NextCure Inc. is 24.707M.

When is the next earnings date for NextCure Inc.?
The upcoming earnings date for NextCure Inc. is Oct 29, 2026.
Click to get the best stock tips daily for free!
ABOUT NEXTCURE INC.
NextCure
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The company is also developing NC410, which is in Phase I for novel immunomedicine designed to block immune sup...
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE